- Report
- September 2025
- 24 Pages
Chile
From €995EUR$1,155USD£864GBP
- Report
- September 2025
- 24 Pages
Colombia
From €995EUR$1,155USD£864GBP
- Report
- September 2025
- 26 Pages
South Korea
From €995EUR$1,155USD£864GBP
- Report
- September 2025
- 23 Pages
Cameroon
From €995EUR$1,155USD£864GBP
- Report
- September 2025
- 23 Pages
Argentina
From €995EUR$1,155USD£864GBP
- Report
- September 2025
- 27 Pages
Austria
From €995EUR$1,155USD£864GBP
From €995EUR$1,155USD£864GBP
- Report
- September 2025
- 22 Pages
Azerbaijan
From €995EUR$1,155USD£864GBP
- Report
- September 2025
- 22 Pages
Bolivia
From €995EUR$1,155USD£864GBP
- Report
- October 2024
- 26 Pages
Ukraine
From €995EUR$1,155USD£864GBP
- Report
- October 2024
- 23 Pages
Morocco
From €995EUR$1,155USD£864GBP
- Report
- February 2026
- 125 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- October 2024
- 74 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- October 2024
- 101 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- April 2023
- 89 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- March 2022
- 89 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- March 2022
- 91 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- February 2024
- 103 Pages
Global
From €3500EUR$4,064USD£3,038GBP
- Report
- January 2024
- 123 Pages
Global
From €3500EUR$4,064USD£3,038GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more